RNA Medicines, Human Genetics & The Future of Obesity Treatment | Dr. Erik Ingelsson, MD, PhD - Chief Scientific Officer, Wave Life Sciences

Episode notes

Send us Fan Mail For decades we've measured obesity using one simple number on a scale - but what if that's the wrong metric? Today, one of the world's leading experts in genetics explains why the future of obesity medicine may not be about losing more weight, but about losing the right kind of fat while preserving the muscle that keeps us healthy. Dr. Erik Ingelsson, MD, PhD is a physician-scientist and internationally recognized leader in human genetics, genomics, and metabolic disease research. He currently serves as Chief Scientific Officer at Wave Life Sciences ( ), where he leads the development of next-generation RNA medicines designed to address major unmet medical needs. Before joining Wave, Dr. Ingelsson served as Senior Vice President and Head of Target Discovery at GSK, where he led large-scale efforts integrating human genetics, functional genomics, computational biology, and molecular science to discover and validate new drug targets across therapeutic areas. Prior to his transition into industry, Dr.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• The Simple Habits That Can 10x Your Business and Life (with Dan Go) | Ep 48The SaaS Academy Podcast · on Metabolic health65 / 100
• The Business & Science Behind the GLP-1 BoomCareTalk: Healthcare. Unfiltered. · on weight loss64 / 100
• Helping People Live Better: Marketing's Role in the Future of Health with Google, Novo Nordisk and BayerThe CMO Podcast · on Metabolic health49 / 100
• Why Most Weight Loss Programs Fail: Data Beats Diets with Timothy ChinniahFood Tech Talk · on Metabolic health
• Can GLP-1 medications help in addiction treatment?Heart of the Matter · on glp1
• 049_Breaking the Mold: Building a Unique Brand in a Crowded Wellness MarketExcellence In Healthcare Podcast · on weight loss

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• Reversing Cellular Age: The Scientist Who Helped Create iPS Cells Reveals What’s Next - Dr. Koji Tanabe, Ph.D. - Founder and CEO, I Peace Inc.
• Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-Colton
• The End of High Cholesterol? The First Oral PCSK9 Drug Could Change Heart Medicine Forever - Dr. Norman Lepor, MD - Founder and Director, National Heart Institute
• The Hidden Heart Risk: Amgen’s Dr. Paul Burton on the Future of Preventing Heart Attacks - Dr. Paul Burton, M.D., Ph.D., F.A.C.C., M.R.C.S., F.R.C.P. - Senior Vice President and Chief Medical Officer - Amgen